Background
Ocumove ApS was founded by psychiatrist Stefan Bjerrum, who has identified a need for an objective and cost effective method for sleep stage measurement in the medical treatment of patients with depression.
Stakeholders
After a succesful POT project supported by MTIC and Accelerace, Ocumove ApS has managed to raise capital from investors SEED Capital and WelfareTech Invest. The funding will finance the design and development a CE-marked medical device ready for EU-market launch second quarter 2016.